AmSouth Bancorp.: Corporate Analysis
| Publication Date | May 2008 |
|---|---|
| Publisher | Daedal Research |
| Product Type | Report |
| Pages | 25 |
| ISBN Number | not applicable |
| Product Code | DAE02180 |
Summary
This company profile is a premium company information product offering an unmatched depth and breadth of content. It analyzes the strategic positioning of the company - how the company has evolved and how it has been performing over the years.
Sectional Highlights
- Structure of the organization, partnerships, mergers & acquisitions and recent developments have been examined
- Business segments of the company have been explored alongwith analysis of key products and services
- SWOT Analysis highlights the weaknesses of the company and the threats to which it is exposed; the strengths of the company and the way the company has positioned itself to take advantage of the opportunities
- Business and marketing strategies boosting earnings, brand value and competitive edge have been discussed
- Key financial indicators have been analyzed
- Competitive positioning of the company has been evaluated in terms of sales, profitability and stock performance, as compared to its competitors
Key Benefits
- Provides input for strategic business planning
- Targets business opportunities & risks
- Exploits competitive intelligence
Target Audience
- Investment Managers
- Venture Capitalists
- Management Consultants
- Research Companies
- Other Industry Professionals
Content
- 1. Company Backgrounder
- 1.1 Corporate Overview
- 1.2 Key Facts
- 1.3 Corporate Timeline
- 2. Business Focus
- 2.1 Major Segments
- 2.2 Products & Services
- 3. Corporate Overview
- 3.1 Organizational Structure
- 3.2 Executive Biographies
- 3.3 Ownership Structure
- 3.4 Subsidiaries
- 3.5 Key Partnerships
- 3.6 Mergers & Acquisitions
- 3.7 Significant Developments
- 4. Strategic Analysis
- 4.1 SWOT
- 4.1.1 Strengths
- 4.1.2 Weaknesses
- 4.1.3 Opportunities
- 4.1.4 Threats
- 4.2 Strategic Focus
- 5. Financial Analysis
- 5.1 Financial Performance
- 5.2 Sales and Earnings Analysis
- 5.3 Ratio Analysis
- 5.4 Stock Performance
- 6. Competitor Analysis
- 6.1 Major Competitors
- 6.2 Peer Comparison at a Glance
- 6.3 Financial Comparison
- 6.4 Stock Chart
- 7. Company Outlook
- 7.1 Revenue & Income Estimates
- Tables:
- 1. Key Facts
- 2. Ownership Structure
- 3. Mergers & Acquisitions
- 4. Subsidiaries
- 5. Key Financials
- 6. Peer Comparison at a Glance
- Charts:
- 1. Corporate Timeline
- 2. Organizational Structure
- 3. Revenue by Business Segments
- 4. Revenue by Geography
- 5. Sales & Profit Growth
- 6. Key Ratios
- 7. 1-Year Stock Chart
- 8. Comparative Stock Chart
- 9. Market Capitalization: Comparison with peers
- 10. Revenue & Net Income Growth: Comparison with Peers
- 11. Revenue & Profit Estimates
About this Product
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















